Determination of the renal function on the basis of the plasmaclearance of iodinated radiocontrast agend after radiography studies on critical care patients

Recruiting

• Conditions: N17; Acute renal failure

• Registration Number: DRKS00031449
• Lead Sponsor: niversitätsklinikum Regensburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-03-09
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

At critical care ward, Iohexol is given for a procedure irrespective of the study.

Exclusion Criteria

Any of the following while samples are being obtained: ECMO therapy, renal replacement therapy or large volume shifts (f.i. massive transfusion or large blood loss). Pregnancy.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Feasibility of measurement of renal function (mGFR) based on Iohexolclearance

Secondary Outcome Measures

Name	Time	Method
Comparison of mGFR (based on Iohexol based) with eGFR (Creatinin/Cystacin-C based)